1 Human Immumoglobulin (PH4) for Intravenous Injection Market Overview 1.1 Human Immumoglobulin (PH4) for Intravenous Injection Product Overview 1.2 Human Immumoglobulin (PH4) for Intravenous Injection Market Segment by Type 1.2.1 1g/20ml 1.2.2 1.25g/25ml 1.2.3 2.5g/50ml 1.2.4 5g/100ml 1.2.5 10g/200ml 1.3 Global Human Immumoglobulin (PH4) for Intravenous Injection Market Size by Type 1.3.1 Global Human Immumoglobulin (PH4) for Intravenous Injection Market Size Overview by Type (2016-2027) 1.3.2 Global Human Immumoglobulin (PH4) for Intravenous Injection Historic Market Size Review by Type (2016-2021) 1.3.2.1 Global Human Immumoglobulin (PH4) for Intravenous Injection Sales Breakdown in Volume by Type (2016-2021) 1.3.2.2 Global Human Immumoglobulin (PH4) for Intravenous Injection Sales Breakdown in Value by Type (2016-2021) 1.3.2.3 Global Human Immumoglobulin (PH4) for Intravenous Injection Average Selling Price (ASP) by Type (2016-2021) 1.3.3 Global Human Immumoglobulin (PH4) for Intravenous Injection Forecasted Market Size by Type (2022-2027) 1.3.3.1 Global Human Immumoglobulin (PH4) for Intravenous Injection Sales Breakdown in Volume by Type (2022-2027) 1.3.3.2 Global Human Immumoglobulin (PH4) for Intravenous Injection Sales Breakdown in Value by Type (2022-2027) 1.3.3.3 Global Human Immumoglobulin (PH4) for Intravenous Injection Average Selling Price (ASP) by Type (2022-2027) 1.4 Key Regions Market Size Segment by Type 1.4.1 North America Human Immumoglobulin (PH4) for Intravenous Injection Sales Breakdown by Type (2016-2021) 1.4.2 Europe Human Immumoglobulin (PH4) for Intravenous Injection Sales Breakdown by Type (2016-2021) 1.4.3 Asia-Pacific Human Immumoglobulin (PH4) for Intravenous Injection Sales Breakdown by Type (2016-2021) 1.4.4 Latin America Human Immumoglobulin (PH4) for Intravenous Injection Sales Breakdown by Type (2016-2021) 1.4.5 Middle East and Africa Human Immumoglobulin (PH4) for Intravenous Injection Sales Breakdown by Type (2016-2021) 2 Global Human Immumoglobulin (PH4) for Intravenous Injection Market Competition by Company 2.1 Global Top Players by Human Immumoglobulin (PH4) for Intravenous Injection Sales (2016-2021) 2.2 Global Top Players by Human Immumoglobulin (PH4) for Intravenous Injection Revenue (2016-2021) 2.3 Global Top Players Human Immumoglobulin (PH4) for Intravenous Injection Price (2016-2021) 2.4 Global Top Manufacturers Human Immumoglobulin (PH4) for Intravenous Injection Manufacturing Base Distribution, Sales Area, Product Type 2.5 Human Immumoglobulin (PH4) for Intravenous Injection Market Competitive Situation and Trends 2.5.1 Human Immumoglobulin (PH4) for Intravenous Injection Market Concentration Rate (2016-2021) 2.5.2 Global 5 and 10 Largest Manufacturers by Human Immumoglobulin (PH4) for Intravenous Injection Sales and Revenue in 2020 2.6 Global Top Manufacturers by Company Type (Tier 1, Tier 2 and Tier 3) & (based on the Revenue in Human Immumoglobulin (PH4) for Intravenous Injection as of 2020) 2.7 Date of Key Manufacturers Enter into Human Immumoglobulin (PH4) for Intravenous Injection Market 2.8 Key Manufacturers Human Immumoglobulin (PH4) for Intravenous Injection Product Offered 2.9 Mergers & Acquisitions, Expansion 3 Human Immumoglobulin (PH4) for Intravenous Injection Status and Outlook by Region 3.1 Global Human Immumoglobulin (PH4) for Intravenous Injection Market Size and CAGR by Region: 2016 VS 2021 VS 2026 3.2 Global Human Immumoglobulin (PH4) for Intravenous Injection Historic Market Size by Region 3.2.1 Global Human Immumoglobulin (PH4) for Intravenous Injection Sales in Volume by Region (2016-2021) 3.2.2 Global Human Immumoglobulin (PH4) for Intravenous Injection Sales in Value by Region (2016-2021) 3.2.3 Global Human Immumoglobulin (PH4) for Intravenous Injection Sales (Volume & Value) Price and Gross Margin (2016-2021) 3.3 Global Human Immumoglobulin (PH4) for Intravenous Injection Forecasted Market Size by Region 3.3.1 Global Human Immumoglobulin (PH4) for Intravenous Injection Sales in Volume by Region (2022-2027) 3.3.2 Global Human Immumoglobulin (PH4) for Intravenous Injection Sales in Value by Region (2022-2027) 3.3.3 Global Human Immumoglobulin (PH4) for Intravenous Injection Sales (Volume & Value), Price and Gross Margin (2022-2027) 4 Global Human Immumoglobulin (PH4) for Intravenous Injection by Application 4.1 Human Immumoglobulin (PH4) for Intravenous Injection Market Segment by Application 4.1.1 Hospital 4.1.2 Clinic 4.1.3 Others 4.2 Global Human Immumoglobulin (PH4) for Intravenous Injection Market Size by Application 4.2.1 Global Human Immumoglobulin (PH4) for Intravenous Injection Market Size Overview by Application (2016-2027) 4.2.2 Global Human Immumoglobulin (PH4) for Intravenous Injection Historic Market Size Review by Application (2016-2021) 4.2.2.1 Global Human Immumoglobulin (PH4) for Intravenous Injection Sales Breakdown in Volume, by Application (2016-2021) 4.2.2.2 Global Human Immumoglobulin (PH4) for Intravenous Injection Sales Breakdown in Value, by Application (2016-2021) 4.2.2.3 Global Human Immumoglobulin (PH4) for Intravenous Injection Average Selling Price (ASP) by Application (2016-2021) 4.2.3 Global Human Immumoglobulin (PH4) for Intravenous Injection Forecasted Market Size by Application (2022-2027) 4.2.3.1 Global Human Immumoglobulin (PH4) for Intravenous Injection Sales Breakdown in Volume, by Application (2022-2027) 4.2.3.2 Global Human Immumoglobulin (PH4) for Intravenous Injection Sales Breakdown in Value, by Application (2022-2027) 4.2.3.3 Global Human Immumoglobulin (PH4) for Intravenous Injection Average Selling Price (ASP) by Application (2022-2027) 4.3 Key Regions Market Size Segment by Application 4.3.1 North America Human Immumoglobulin (PH4) for Intravenous Injection Sales Breakdown by Application (2016-2021) 4.3.2 Europe Human Immumoglobulin (PH4) for Intravenous Injection Sales Breakdown by Application (2016-2021) 4.3.3 Asia-Pacific Human Immumoglobulin (PH4) for Intravenous Injection Sales Breakdown by Application (2016-2021) 4.3.4 Latin America Human Immumoglobulin (PH4) for Intravenous Injection Sales Breakdown by Application (2016-2021) 4.3.5 Middle East and Africa Human Immumoglobulin (PH4) for Intravenous Injection Sales Breakdown by Application (2016-2021) 5 North America Human Immumoglobulin (PH4) for Intravenous Injection by Country 5.1 North America Human Immumoglobulin (PH4) for Intravenous Injection Historic Market Size by Country 5.1.1 North America Human Immumoglobulin (PH4) for Intravenous Injection Sales in Volume by Country (2016-2021) 5.1.2 North America Human Immumoglobulin (PH4) for Intravenous Injection Sales in Value by Country (2016-2021) 5.2 North America Human Immumoglobulin (PH4) for Intravenous Injection Forecasted Market Size by Country 5.2.1 North America Human Immumoglobulin (PH4) for Intravenous Injection Sales in Volume by Country (2022-2027) 5.2.2 North America Human Immumoglobulin (PH4) for Intravenous Injection Sales in Value by Country (2022-2027) 6 Europe Human Immumoglobulin (PH4) for Intravenous Injection by Country 6.1 Europe Human Immumoglobulin (PH4) for Intravenous Injection Historic Market Size by Country 6.1.1 Europe Human Immumoglobulin (PH4) for Intravenous Injection Sales in Volume by Country (2016-2021) 6.1.2 Europe Human Immumoglobulin (PH4) for Intravenous Injection Sales in Value by Country (2016-2021) 6.2 Europe Human Immumoglobulin (PH4) for Intravenous Injection Forecasted Market Size by Country 6.2.1 Europe Human Immumoglobulin (PH4) for Intravenous Injection Sales in Volume by Country (2022-2027) 6.2.2 Europe Human Immumoglobulin (PH4) for Intravenous Injection Sales in Value by Country (2022-2027) 7 Asia-Pacific Human Immumoglobulin (PH4) for Intravenous Injection by Region 7.1 Asia-Pacific Human Immumoglobulin (PH4) for Intravenous Injection Historic Market Size by Region 7.1.1 Asia-Pacific Human Immumoglobulin (PH4) for Intravenous Injection Sales in Volume by Region (2016-2021) 7.1.2 Asia-Pacific Human Immumoglobulin (PH4) for Intravenous Injection Sales in Value by Region (2016-2021) 7.2 Asia-Pacific Human Immumoglobulin (PH4) for Intravenous Injection Forecasted Market Size by Region 7.2.1 Asia-Pacific Human Immumoglobulin (PH4) for Intravenous Injection Sales in Volume by Region (2022-2027) 7.2.2 Asia-Pacific Human Immumoglobulin (PH4) for Intravenous Injection Sales in Value by Region (2022-2027) 8 Latin America Human Immumoglobulin (PH4) for Intravenous Injection by Country 8.1 Latin America Human Immumoglobulin (PH4) for Intravenous Injection Historic Market Size by Country 8.1.1 Latin America Human Immumoglobulin (PH4) for Intravenous Injection Sales in Volume by Country (2016-2021) 8.1.2 Latin America Human Immumoglobulin (PH4) for Intravenous Injection Sales in Value by Country (2016-2021) 8.2 Latin America Human Immumoglobulin (PH4) for Intravenous Injection Forecasted Market Size by Country 8.2.1 Latin America Human Immumoglobulin (PH4) for Intravenous Injection Sales in Volume by Country (2022-2027) 8.2.2 Latin America Human Immumoglobulin (PH4) for Intravenous Injection Sales in Value by Country (2022-2027) 9 Middle East and Africa Human Immumoglobulin (PH4) for Intravenous Injection by Country 9.1 Middle East and Africa Human Immumoglobulin (PH4) for Intravenous Injection Historic Market Size by Country 9.1.1 Middle East and Africa Human Immumoglobulin (PH4) for Intravenous Injection Sales in Volume by Country (2016-2021) 9.1.2 Middle East and Africa Human Immumoglobulin (PH4) for Intravenous Injection Sales in Value by Country (2016-2021) 9.2 Middle East and Africa Human Immumoglobulin (PH4) for Intravenous Injection Forecasted Market Size by Country 9.2.1 Middle East and Africa Human Immumoglobulin (PH4) for Intravenous Injection Sales in Volume by Country (2022-2027) 9.2.2 Middle East and Africa Human Immumoglobulin (PH4) for Intravenous Injection Sales in Value by Country (2022-2027) 10 Company Profiles and Key Figures in Human Immumoglobulin (PH4) for Intravenous Injection Business 10.1 Boya-Bio 10.1.1 Boya-Bio Corporation Information 10.1.2 Boya-Bio Introduction and Business Overview 10.1.3 Boya-Bio Human Immumoglobulin (PH4) for Intravenous Injection Sales, Revenue and Gross Margin (2016-2021) 10.1.4 Boya-Bio Human Immumoglobulin (PH4) for Intravenous Injection Products Offered 10.1.5 Boya-Bio Recent Development 10.2 Beijing Tiantan Biological Products 10.2.1 Beijing Tiantan Biological Products Corporation Information 10.2.2 Beijing Tiantan Biological Products Introduction and Business Overview 10.2.3 Beijing Tiantan Biological Products Human Immumoglobulin (PH4) for Intravenous Injection Sales, Revenue and Gross Margin (2016-2021) 10.2.4 Boya-Bio Human Immumoglobulin (PH4) for Intravenous Injection Products Offered 10.2.5 Beijing Tiantan Biological Products Recent Development 10.3 Guangdong Shuagnlin Bio-pharmacy 10.3.1 Guangdong Shuagnlin Bio-pharmacy Corporation Information 10.3.2 Guangdong Shuagnlin Bio-pharmacy Introduction and Business Overview 10.3.3 Guangdong Shuagnlin Bio-pharmacy Human Immumoglobulin (PH4) for Intravenous Injection Sales, Revenue and Gross Margin (2016-2021) 10.3.4 Guangdong Shuagnlin Bio-pharmacy Human Immumoglobulin (PH4) for Intravenous Injection Products Offered 10.3.5 Guangdong Shuagnlin Bio-pharmacy Recent Development 10.4 Weiguang Biological 10.4.1 Weiguang Biological Corporation Information 10.4.2 Weiguang Biological Introduction and Business Overview 10.4.3 Weiguang Biological Human Immumoglobulin (PH4) for Intravenous Injection Sales, Revenue and Gross Margin (2016-2021) 10.4.4 Weiguang Biological Human Immumoglobulin (PH4) for Intravenous Injection Products Offered 10.4.5 Weiguang Biological Recent Development 10.5 Hualan Bio 10.5.1 Hualan Bio Corporation Information 10.5.2 Hualan Bio Introduction and Business Overview 10.5.3 Hualan Bio Human Immumoglobulin (PH4) for Intravenous Injection Sales, Revenue and Gross Margin (2016-2021) 10.5.4 Hualan Bio Human Immumoglobulin (PH4) for Intravenous Injection Products Offered 10.5.5 Hualan Bio Recent Development 10.6 CTBB 10.6.1 CTBB Corporation Information 10.6.2 CTBB Introduction and Business Overview 10.6.3 CTBB Human Immumoglobulin (PH4) for Intravenous Injection Sales, Revenue and Gross Margin (2016-2021) 10.6.4 CTBB Human Immumoglobulin (PH4) for Intravenous Injection Products Offered 10.6.5 CTBB Recent Development 10.7 Sinopharm 10.7.1 Sinopharm Corporation Information 10.7.2 Sinopharm Introduction and Business Overview 10.7.3 Sinopharm Human Immumoglobulin (PH4) for Intravenous Injection Sales, Revenue and Gross Margin (2016-2021) 10.7.4 Sinopharm Human Immumoglobulin (PH4) for Intravenous Injection Products Offered 10.7.5 Sinopharm Recent Development 10.8 Nanyue Biopharming 10.8.1 Nanyue Biopharming Corporation Information 10.8.2 Nanyue Biopharming Introduction and Business Overview 10.8.3 Nanyue Biopharming Human Immumoglobulin (PH4) for Intravenous Injection Sales, Revenue and Gross Margin (2016-2021) 10.8.4 Nanyue Biopharming Human Immumoglobulin (PH4) for Intravenous Injection Products Offered 10.8.5 Nanyue Biopharming Recent Development 10.9 Shanghai RAAS 10.9.1 Shanghai RAAS Corporation Information 10.9.2 Shanghai RAAS Introduction and Business Overview 10.9.3 Shanghai RAAS Human Immumoglobulin (PH4) for Intravenous Injection Sales, Revenue and Gross Margin (2016-2021) 10.9.4 Shanghai RAAS Human Immumoglobulin (PH4) for Intravenous Injection Products Offered 10.9.5 Shanghai RAAS Recent Development 11 Upstream, Opportunities, Challenges, Risks and Influences Factors Analysis 11.1 Human Immumoglobulin (PH4) for Intravenous Injection Key Raw Materials 11.1.1 Key Raw Materials 11.1.2 Key Raw Materials Price 11.1.3 Raw Materials Key Suppliers 11.2 Manufacturing Cost Structure 11.2.1 Raw Materials 11.2.2 Labor Cost 11.2.3 Manufacturing Expenses 11.3 Human Immumoglobulin (PH4) for Intravenous Injection Industrial Chain Analysis 11.4 Human Immumoglobulin (PH4) for Intravenous Injection Market Dynamics 11.4.1 Industry Trends 11.4.2 Market Drivers 11.4.3 Market Challenges 11.4.4 Market Restraints 12 Market Strategy Analysis, Distributors 12.1 Sales Channel 12.2 Human Immumoglobulin (PH4) for Intravenous Injection Distributors 12.3 Human Immumoglobulin (PH4) for Intravenous Injection Downstream Customers 13 Research Findings and Conclusion 14 Appendix 14.1 Research Methodology 14.1.1 Methodology/Research Approach 14.1.1.1 Research Programs/Design 14.1.1.2 Market Size Estimation 14.1.1.3 Market Breakdown and Data Triangulation 14.1.2 Data Source 14.1.2.1 Secondary Sources 14.1.2.2 Primary Sources 14.2 Author Details 14.3 Disclaimer

List of Tables Table 1. Major Company of 1g/20ml Table 2. Major Company of 1.25g/25ml Table 3. Major Company of 2.5g/50ml Table 4. Major Company of 5g/100ml Table 5. Major Company of 10g/200ml Table 6. Global Human Immumoglobulin (PH4) for Intravenous Injection Sales by Type 2016 VS 2021 VS 2027 (US$ Million) Table 7. Global Human Immumoglobulin (PH4) for Intravenous Injection Sales by Type (2016-2021) & (K Units) Table 8. Global Human Immumoglobulin (PH4) for Intravenous Injection Sales Market Share in Volume by Type (2016-2021) Table 9. Global Human Immumoglobulin (PH4) for Intravenous Injection Sales by Type (2016-2021) & (US& Million) Table 10. Global Human Immumoglobulin (PH4) for Intravenous Injection Market Share in Value by Type (2016-2021) Table 11. Global Human Immumoglobulin (PH4) for Intravenous Injection Price by Type (2016-2021) & (US$/Unit) Table 12. Global Human Immumoglobulin (PH4) for Intravenous Injection Sales by Type (2022-2027) & (K Units) Table 13. Global Human Immumoglobulin (PH4) for Intravenous Injection Sales Market Share in Volume by Type (2022-2027) Table 14. Global Human Immumoglobulin (PH4) for Intravenous Injection Sales by Type (2022-2027) & (US$ Million) Table 15. Global Human Immumoglobulin (PH4) for Intravenous Injection Sales Market Share in Value by Type (2022-2027) Table 16. Global Human Immumoglobulin (PH4) for Intravenous Injection Price by Type (2022-2027) & (US$/Unit) Table 17. North America Human Immumoglobulin (PH4) for Intravenous Injection Sales by Type (2016-2021) & (K Units) Table 18. North America Human Immumoglobulin (PH4) for Intravenous Injection Sales by Type (2016-2021) & (US$ Million) Table 19. Europe Human Immumoglobulin (PH4) for Intravenous Injection Sales (K Units) by Type (2016-2021) Table 20. Europe Human Immumoglobulin (PH4) for Intravenous Injection Sales by Type (2016-2021) & (US$ Million) Table 21. Asia-Pacific Human Immumoglobulin (PH4) for Intravenous Injection Sales (K Units) by Type (2016-2021) Table 22. Asia-Pacific Human Immumoglobulin (PH4) for Intravenous Injection Sales by Type (2016-2021) & (US$ Million) Table 23. Latin America Human Immumoglobulin (PH4) for Intravenous Injection Sales (K Units) by Type (2016-2021) Table 24. Latin America Human Immumoglobulin (PH4) for Intravenous Injection Sales by Type (2016-2021) & (US$ Million) Table 25. Middle East and Africa Human Immumoglobulin (PH4) for Intravenous Injection Sales (K Units) by Type (2016-2021) Table 26. Middle East and Africa Human Immumoglobulin (PH4) for Intravenous Injection Sales by Type (2016-2021) & (US$ Million) Table 27. Global Human Immumoglobulin (PH4) for Intravenous Injection Sales by Company (2016-2021) & (K Units) Table 28. Global Human Immumoglobulin (PH4) for Intravenous Injection Sales Share by Company (2016-2021) Table 29. Global Human Immumoglobulin (PH4) for Intravenous Injection Revenue by Company (2016-2021) & (US$ Million) Table 30. Global Human Immumoglobulin (PH4) for Intravenous Injection Revenue Share by Company (2016-2021) Table 31. Global Market Human Immumoglobulin (PH4) for Intravenous Injection Price by Company (2016-2021) & (US$/Unit) Table 32. Global Human Immumoglobulin (PH4) for Intravenous Injection Top Manufacturers Manufacturing Base Distribution and Sales Area Table 33. Global Human Immumoglobulin (PH4) for Intravenous Injection Manufacturers Market Concentration Ratio (CR5 and HHI) Table 34. Global Top Manufacturers Market Share by Company Type (Tier 1, Tier 2 and Tier 3) & (based on the Revenue in Human Immumoglobulin (PH4) for Intravenous Injection as of 2020 Table 35. Date of Key Manufacturers Enter into Human Immumoglobulin (PH4) for Intravenous Injection Market Table 36. Key Manufacturers Human Immumoglobulin (PH4) for Intravenous Injection Product Type Table 37. Mergers & Acquisitions, Expansion Plans Table 38. Global Human Immumoglobulin (PH4) for Intravenous Injection Market Size Comparison by Region (US$ Million): 2016 VS 2021 VS 2027 Table 39. Global Human Immumoglobulin (PH4) for Intravenous Injection Sales by Region (2016-2021) & (K Units) Table 40. Global Human Immumoglobulin (PH4) for Intravenous Injection Sales Market Share in Volume by Region (2016-2021) Table 41. Global Human Immumoglobulin (PH4) for Intravenous Injection Sales by Region (2016-2021) & (US$ Million) Table 42. Global Human Immumoglobulin (PH4) for Intravenous Injection Sales Market Share in Value by Region (2016-2021) Table 43. Global Human Immumoglobulin (PH4) for Intravenous Injection Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2016-2021) Table 44. Global Human Immumoglobulin (PH4) for Intravenous Injection Sales by Region (2022-2027) & (K Units) Table 45. Global Human Immumoglobulin (PH4) for Intravenous Injection Sales Market Share in Volume by Region (2022-2027) Table 46. Global Human Immumoglobulin (PH4) for Intravenous Injection Sales by Region (2022-2027) & (US$ Million) Table 47. Global Human Immumoglobulin (PH4) for Intravenous Injection Sales Market Share in Value by Region (2022-2027) Table 48. Global Human Immumoglobulin (PH4) for Intravenous Injection Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2022-2027) Table 49. Global Human Immumoglobulin (PH4) for Intravenous Injection Sales by Application: 2016 VS 2021 VS 2027 (US$ Million) Table 50. Global Human Immumoglobulin (PH4) for Intravenous Injection Sales by Application (2016-2021) & (K Units) Table 51. Global Human Immumoglobulin (PH4) for Intravenous Injection Sales Market Share in Volume by Application (2016-2021) Table 52. Global Human Immumoglobulin (PH4) for Intravenous Injection Sales by Application (2016-2021) & (US$ Million) Table 53. Global Human Immumoglobulin (PH4) for Intravenous Injection Sales Market Share in Value by Application (2016-2021) Table 54. Global Human Immumoglobulin (PH4) for Intravenous Injection Price by Application (2016-2021) & (US$/Unit) Table 55. Global Human Immumoglobulin (PH4) for Intravenous Injection Sales by Application (2022-2027) & (K Units) Table 56. Global Human Immumoglobulin (PH4) for Intravenous Injection Sales Market Share in Volume by Application (2022-2027) Table 57. Global Human Immumoglobulin (PH4) for Intravenous Injection Sales by Application (2022-2027) & (US$ Million) Table 58. Global Human Immumoglobulin (PH4) for Intravenous Injection Sales Market Share in Value by Application (2022-2027) Table 59. Global Human Immumoglobulin (PH4) for Intravenous Injection Price by Application (2022-2027) & (US$/Unit) Table 60. North America Human Immumoglobulin (PH4) for Intravenous Injection Sales by Application (2016-2021) (K Units) Table 61. North America Human Immumoglobulin (PH4) for Intravenous Injection Sales by Application (2016-2021) & (US$ Million) Table 62. North America Human Immumoglobulin (PH4) for Intravenous Injection Sales Market Share in Value by Application in 2020 Table 63. Europe Human Immumoglobulin (PH4) for Intravenous Injection Sales by Application (2016-2021) (K Units) Table 64. Europe Human Immumoglobulin (PH4) for Intravenous Injection Sales by Application (2016-2021) & (US$ Million) Table 65. Europe Human Immumoglobulin (PH4) for Intravenous Injection Sales Market Share in Value by Application in 2020 Table 66. Asia-Pacific Human Immumoglobulin (PH4) for Intravenous Injection Sales by Application (2016-2021) (K Units) Table 67. Asia-Pacific Human Immumoglobulin (PH4) for Intravenous Injection Sales by Application (2016-2021) & (US$ Million) Table 68. Asia-Pacific Human Immumoglobulin (PH4) for Intravenous Injection Sales Market Share in Value by Application in 2020 Table 69. Latin America Human Immumoglobulin (PH4) for Intravenous Injection Sales by Application (2016-2021) (K Units) Table 70. Latin America Human Immumoglobulin (PH4) for Intravenous Injection Sales by Application (2016-2021) & (US$ Million) Table 71. Latin America Human Immumoglobulin (PH4) for Intravenous Injection Sales Market Share in Value by Application in 2020 Table 72. Middle East and Africa Human Immumoglobulin (PH4) for Intravenous Injection Sales by Application (2016-2021) (K Units) Table 73. Middle East and Africa Human Immumoglobulin (PH4) for Intravenous Injection Sales by Application (2016-2021) & (US$ Million) Table 74. Middle East and Africa Human Immumoglobulin (PH4) for Intravenous Injection Sales Market Share in Value by Application in 2020 Table 75. North America Human Immumoglobulin (PH4) for Intravenous Injection Sales by Country (2016-2021) & (K Units) Table 76. North America Human Immumoglobulin (PH4) for Intravenous Injection Sales Market Share in Volume by Country (2016-2021) Table 77. North America Human Immumoglobulin (PH4) for Intravenous Injection Sales by Country (2016-2021) & (US$ Million) Table 78. North America Human Immumoglobulin (PH4) for Intravenous Injection Sales Market Share in Value by Country (2016-2021) Table 79. North America Human Immumoglobulin (PH4) for Intravenous Injection Sales by Country (2022-2027) & (K Units) Table 80. North America Human Immumoglobulin (PH4) for Intravenous Injection Sales Market Share in Volume by Country (2022-2027) Table 81. North America Human Immumoglobulin (PH4) for Intravenous Injection Sales by Country (2022-2027) & (US$ Million) Table 82. North America Human Immumoglobulin (PH4) for Intravenous Injection Sales Market Share in Value by Country (2022-2027) Table 83. Europe Human Immumoglobulin (PH4) for Intravenous Injection Sales by Country (2016-2021) & (K Units) Table 84. Europe Human Immumoglobulin (PH4) for Intravenous Injection Sales Market Share in Volume by Country (2016-2021) Table 85. Europe Human Immumoglobulin (PH4) for Intravenous Injection Sales by Country (2016-2021) & (US$ Million) Table 86. Europe Human Immumoglobulin (PH4) for Intravenous Injection Sales Market Share in Value by Country (2016-2021) Table 87. Europe Human Immumoglobulin (PH4) for Intravenous Injection Sales by Country (2022-2027) & (K Units) Table 88. Europe Human Immumoglobulin (PH4) for Intravenous Injection Sales Market Share in Volume by Country (2022-2027) Table 89. Europe Human Immumoglobulin (PH4) for Intravenous Injection Sales by Country (2022-2027) & (US$ Million) Table 90. Europe Human Immumoglobulin (PH4) for Intravenous Injection Sales Market Share in Value by Country (2022-2027) Table 91. Asia-Pacific Human Immumoglobulin (PH4) for Intravenous Injection Sales by Region (2016-2021) & (K Units) Table 92. Asia-Pacific Human Immumoglobulin (PH4) for Intravenous Injection Sales Market Share in Volume by Region (2016-2021) Table 93. Asia-Pacific Human Immumoglobulin (PH4) for Intravenous Injection Sales by Region (2016-2021) & (US$ Million) Table 94. Asia-Pacific Human Immumoglobulin (PH4) for Intravenous Injection Sales Market Share in Value by Region (2016-2021) Table 95. Asia-Pacific Human Immumoglobulin (PH4) for Intravenous Injection Sales by Region (2022-2027) & (K Units) Table 96. Asia-Pacific Human Immumoglobulin (PH4) for Intravenous Injection Sales Market Share in Volume by Region (2022-2027) Table 97. Asia-Pacific Human Immumoglobulin (PH4) for Intravenous Injection Sales by Region (2022-2027) & (US$ Million) Table 98. Asia-Pacific Human Immumoglobulin (PH4) for Intravenous Injection Sales Market Share in Value by Region (2022-2027) Table 99. Latin America Human Immumoglobulin (PH4) for Intravenous Injection Sales by Country (2016-2021) & (K Units) Table 100. Latin America Human Immumoglobulin (PH4) for Intravenous Injection Sales Market Share in Volume by Country (2016-2021) Table 101. Latin America Human Immumoglobulin (PH4) for Intravenous Injection Sales by Country (2016-2021) & (US$ Million) Table 102. Latin America Human Immumoglobulin (PH4) for Intravenous Injection Sales Market Share in Value by Country (2016-2021) Table 103. Latin America Human Immumoglobulin (PH4) for Intravenous Injection Sales by Country (2022-2027) & (K Units) Table 104. Latin America Human Immumoglobulin (PH4) for Intravenous Injection Sales Market Share in Volume by Country (2022-2027) Table 105. Latin America Human Immumoglobulin (PH4) for Intravenous Injection Sales by Country (2022-2027) & (US$ Million) Table 106. Latin America Human Immumoglobulin (PH4) for Intravenous Injection Sales Market Share in Value by Country (2022-2027) Table 107. Middle East and Africa Human Immumoglobulin (PH4) for Intravenous Injection Sales by Country (2016-2021) & (K Units) Table 108. Middle East and Africa Human Immumoglobulin (PH4) for Intravenous Injection Sales Market Share in Volume by Country (2016-2021) Table 109. Middle East and Africa Human Immumoglobulin (PH4) for Intravenous Injection Sales by Country (2016-2021) & (US$ Million) Table 110. Middle East and Africa Human Immumoglobulin (PH4) for Intravenous Injection Sales Market Share in Value by Country (2016-2021) Table 111. Middle East and Africa Human Immumoglobulin (PH4) for Intravenous Injection Sales by Country (2022-2027) & (K Units) Table 112. Middle East and Africa Human Immumoglobulin (PH4) for Intravenous Injection Sales Market Share in Volume by Country (2022-2027) Table 113. Middle East and Africa Human Immumoglobulin (PH4) for Intravenous Injection Sales by Country (2022-2027) & (US$ Million) Table 114. Middle East and Africa Human Immumoglobulin (PH4) for Intravenous Injection Sales Market Share in Value by Country (2022-2027) Table 115. Boya-Bio Corporation Information Table 116. Boya-Bio Introduction and Business Overview Table 117. Boya-Bio Human Immumoglobulin (PH4) for Intravenous Injection Sales (K Units), Revenue (Million USD), Price (US$/Unit) and Gross Margin (2016-2021) Table 118. Boya-Bio Human Immumoglobulin (PH4) for Intravenous Injection Product Table 119. Boya-Bio Recent Development Table 120. Beijing Tiantan Biological Products Corporation Information Table 121. Beijing Tiantan Biological Products Introduction and Business Overview Table 122. Beijing Tiantan Biological Products Human Immumoglobulin (PH4) for Intravenous Injection Sales (K Units), Revenue (Million USD), Price (US$/Unit) and Gross Margin (2016-2021) Table 123. Beijing Tiantan Biological Products Human Immumoglobulin (PH4) for Intravenous Injection Product Table 124. Beijing Tiantan Biological Products Recent Development Table 125. Guangdong Shuagnlin Bio-pharmacy Corporation Information Table 126. Guangdong Shuagnlin Bio-pharmacy Introduction and Business Overview Table 127. Guangdong Shuagnlin Bio-pharmacy Human Immumoglobulin (PH4) for Intravenous Injection Sales (K Units), Revenue (Million USD), Price (US$/Unit) and Gross Margin (2016-2021) Table 128. Guangdong Shuagnlin Bio-pharmacy Human Immumoglobulin (PH4) for Intravenous Injection Product Table 129. Guangdong Shuagnlin Bio-pharmacy Recent Development Table 130. Weiguang Biological Corporation Information Table 131. Weiguang Biological Introduction and Business Overview Table 132. Weiguang Biological Human Immumoglobulin (PH4) for Intravenous Injection Sales (K Units), Revenue (Million USD), Price (US$/Unit) and Gross Margin (2016-2021) Table 133. Weiguang Biological Human Immumoglobulin (PH4) for Intravenous Injection Product Table 134. Weiguang Biological Recent Development Table 135. Hualan Bio Corporation Information Table 136. Hualan Bio Introduction and Business Overview Table 137. Hualan Bio Human Immumoglobulin (PH4) for Intravenous Injection Sales (K Units), Revenue (Million USD), Price (US$/Unit) and Gross Margin (2016-2021) Table 138. Hualan Bio Human Immumoglobulin (PH4) for Intravenous Injection Product Table 139. Hualan Bio Recent Development Table 140. CTBB Corporation Information Table 141. CTBB Introduction and Business Overview Table 142. CTBB Human Immumoglobulin (PH4) for Intravenous Injection Sales (K Units), Revenue (Million USD), Price (US$/Unit) and Gross Margin (2016-2021) Table 143. CTBB Human Immumoglobulin (PH4) for Intravenous Injection Product Table 144. CTBB Recent Development Table 145. Sinopharm Corporation Information Table 146. Sinopharm Introduction and Business Overview Table 147. Sinopharm Human Immumoglobulin (PH4) for Intravenous Injection Sales (K Units), Revenue (Million USD), Price (US$/Unit) and Gross Margin (2016-2021) Table 148. Sinopharm Human Immumoglobulin (PH4) for Intravenous Injection Product Table 149. Sinopharm Recent Development Table 150. Nanyue Biopharming Corporation Information Table 151. Nanyue Biopharming Introduction and Business Overview Table 152. Nanyue Biopharming Human Immumoglobulin (PH4) for Intravenous Injection Sales (K Units), Revenue (Million USD), Price (US$/Unit) and Gross Margin (2016-2021) Table 153. Nanyue Biopharming Human Immumoglobulin (PH4) for Intravenous Injection Product Table 154. Nanyue Biopharming Recent Development Table 155. Shanghai RAAS Corporation Information Table 156. Shanghai RAAS Introduction and Business Overview Table 157. Shanghai RAAS Human Immumoglobulin (PH4) for Intravenous Injection Sales (K Units), Revenue (Million USD), Price (US$/Unit) and Gross Margin (2016-2021) Table 158. Shanghai RAAS Human Immumoglobulin (PH4) for Intravenous Injection Product Table 159. Shanghai RAAS Recent Development Table 160. Key Raw Materials Lists Table 161. Raw Materials Key Suppliers Lists Table 162. Human Immumoglobulin (PH4) for Intravenous Injection Market Trends Table 163. Human Immumoglobulin (PH4) for Intravenous Injection Market Drivers Table 164. Human Immumoglobulin (PH4) for Intravenous Injection Market Challenges Table 165. Human Immumoglobulin (PH4) for Intravenous Injection Market Restraints Table 166. Human Immumoglobulin (PH4) for Intravenous Injection Distributors List Table 167. Human Immumoglobulin (PH4) for Intravenous Injection Downstream Customers Table 168. Research Programs/Design for This Report Table 169. Key Data Information from Secondary Sources Table 170. Key Data Information from Primary Sources List of Figures Figure 1. Human Immumoglobulin (PH4) for Intravenous Injection Product Picture Figure 2. Global Human Immumoglobulin (PH4) for Intravenous Injection Market Size, 2016 VS 2021 VS 2027 (US$ Million) Figure 3. Global Human Immumoglobulin (PH4) for Intravenous Injection Market Size Status and Outlook (2016-2027) & (US$ Million) Figure 4. Global Human Immumoglobulin (PH4) for Intravenous Injection Sales Status and Outlook (2016-2027) & (K Units) Figure 5. Product Picture of 1g/20ml Figure 6. Global 1g/20ml Sales YoY Growth (2016-2021) & (K Units) Figure 7. Product Picture of 1.25g/25ml Figure 8. Global 1.25g/25ml Sales YoY Growth (2016-2021) & (K Units) Figure 9. Product Picture of 2.5g/50ml Figure 10. Global 2.5g/50ml Sales YoY Growth (2016-2021) & (K Units) Figure 11. Product Picture of 5g/100ml Figure 12. Global 5g/100ml Sales YoY Growth (2016-2021) & (K Units) Figure 13. Product Picture of 10g/200ml Figure 14. Global 10g/200ml Sales YoY Growth (2016-2021) & (K Units) Figure 15. Global Human Immumoglobulin (PH4) for Intravenous Injection Sales by Type (2016-2027) & (US$ Million) Figure 16. Global Human Immumoglobulin (PH4) for Intravenous Injection Sales Market Share in Volume by Type (2016-2021) Figure 17. Global Human Immumoglobulin (PH4) for Intravenous Injection Sales Market Share in Value by Type (2016-2021) Figure 18. Global Human Immumoglobulin (PH4) for Intravenous Injection Sales Market Share in Volume by Type (2022-2027) Figure 19. Global Human Immumoglobulin (PH4) for Intravenous Injection Sales Market Share in Value by Type (2022-2027) Figure 20. North America Human Immumoglobulin (PH4) for Intravenous Injection Sales Market Share in Volume by Type in 2020 Figure 21. North America Human Immumoglobulin (PH4) for Intravenous Injection Sales Market Share in Value by Type in 2020 Figure 22. Europe Human Immumoglobulin (PH4) for Intravenous Injection Sales Market Share in Volume by Type in 2020 Figure 23. Europe Human Immumoglobulin (PH4) for Intravenous Injection Sales Market Share in Value by Type in 2020 Figure 24. Asia-Pacific Human Immumoglobulin (PH4) for Intravenous Injection Sales Market Share in Volume by Type in 2020 Figure 25. Asia-Pacific Human Immumoglobulin (PH4) for Intravenous Injection Sales Market Share in Value by Type in 2020 Figure 26. Latin America Human Immumoglobulin (PH4) for Intravenous Injection Sales Market Share in Volume by Type in 2020 Figure 27. Latin America Human Immumoglobulin (PH4) for Intravenous Injection Sales Market Share in Value by Type in 2020 Figure 28. Middle East and Africa Human Immumoglobulin (PH4) for Intravenous Injection Sales Market Share in Volume by Type in 2020 Figure 29. Middle East and Africa Human Immumoglobulin (PH4) for Intravenous Injection Sales Market Share in Value by Type in 2020 Figure 30. The 5 and 10 Largest Manufacturers in the World: Market Share by Human Immumoglobulin (PH4) for Intravenous Injection Sales in 2020 Figure 31. The 5 and 10 Largest Manufacturers in the World: Market Share by Human Immumoglobulin (PH4) for Intravenous Injection Revenue in 2020 Figure 32. Human Immumoglobulin (PH4) for Intravenous Injection Market Share by Company Type (Tier 1, Tier 2, and Tier 3): 2016 VS 2020 Figure 33. Product Picture of Hospital Figure 34. Global Hospital Sales YoY Growth (2016-2027) & (K Units) Figure 35. Product Picture of Clinic Figure 36. Global Clinic Sales YoY Growth (2016-2027) & (K Units) Figure 37. Product Picture of Others Figure 38. Global Others Sales YoY Growth (2016-2027) & (K Units) Figure 39. Global Human Immumoglobulin (PH4) for Intravenous Injection Sales by Application (2016-2027) & (US$ Million) Figure 40. Global Human Immumoglobulin (PH4) for Intravenous Injection Sales Market Share in Volume by Application (2016-2021) Figure 41. Global Human Immumoglobulin (PH4) for Intravenous Injection Sales Market Share in Value by Application (2016-2021) Figure 42. Global Human Immumoglobulin (PH4) for Intravenous Injection Sales Market Share in Volume by Application (2022-2027) Figure 43. North America Human Immumoglobulin (PH4) for Intravenous Injection Sales Market Share in Volume by Application in 2020 Figure 44. Latin America Human Immumoglobulin (PH4) for Intravenous Injection Sales Market Share in Value by Application in 2020 Figure 45. Middle East and Africa Human Immumoglobulin (PH4) for Intravenous Injection Sales Market Share in Value by Application in 2020 Figure 46. Key Raw Materials Price Figure 47. Human Immumoglobulin (PH4) for Intravenous Injection Manufacturing Cost Structure Figure 48. Human Immumoglobulin (PH4) for Intravenous Injection Industrial Chain Analysis Figure 49. Channels of Distribution Figure 50. Distributors Profiles Figure 51. Bottom-up and Top-down Approaches for This Report Figure 52. Data Triangulation Figure 53. Key Executives Interviewed

Boya-Bio Beijing Tiantan Biological Products Guangdong Shuagnlin Bio-pharmacy Weiguang Biological Hualan Bio CTBB Sinopharm Nanyue Biopharming Shanghai RAAS